Lantern Pharma, Inc. (LTRN)
2.52
+0.21
(+9.09%)
USD |
NASDAQ |
Apr 24, 16:00
2.52
0.00 (0.00%)
After-Hours: 17:45
Lantern Pharma Market Cap : 28.36M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 109.32B |
| BioVie, Inc. | 11.46M |
| Acurx Pharmaceuticals, Inc. | 5.081M |
| ACADIA Pharmaceuticals, Inc. | 3.746B |
| Alnylam Pharmaceuticals, Inc. | 40.54B |
Market Cap Related Metrics
| Price to Book Value | 4.341 |
| Price | 2.52 |
| Earnings Yield | -62.30% |